Document is current
Any future updates will be listed below
-
Authors
Menean, Matteo
Sacconi, Riccardo
Tombolini, Beatrice
Fantaguzzi, Federico
Bandello, Francesco https://orcid.org/0000-0003-3238-9682
Querques, Giuseppe https://orcid.org/0000-0002-3292-9581
- License Information
-
More Information
Article History
Received: 27 October 2022
Revised: 25 June 2023
Accepted: 14 July 2023
First Online: 31 July 2023
Competing interests
: MM, BT, FF have nothing to disclose. RS has the following disclosures: Allergan Inc, Bayer Shering-Pharma, Medivis, Novartis, Zeiss. FB has the following disclosures: Allergan Inc, Bayer Shering-Pharma, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, Oxurion NV, Sifi. GQ has the following disclosures: Alimera Sciences, Allergan Inc, Amgen, Bayer Shering-Pharma, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Sandoz, Sifi, Sooft-Fidea, Zeiss. The authors have no competing interest in publishing the present work.
